Market Overview

Novartis -2.7% Premarket @$70.49, UBS Downgrade from Buy to Neutral

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for NVS

DateFirmActionFromTo
Nov 2016Argus ResearchUpgradesHoldBuy
Sep 2016Chardan CapitalInitiates Coverage onBuy
Apr 2016Morgan StanleyDowngradesEqual-WeightUnderperform

View More Analyst Ratings for NVS
View the Latest Analyst Ratings

Posted-In: UBSNews Downgrades Price Target Legal Pre-Market Outlook Analyst Ratings Movers

 

Related Articles (NVS)